Officials of global healthcare company Haemonetics, a global leader in innovative blood management solutions, have announced plans to expand the company's operations in Union County, South Carolina.
The expansion is a $20-million investment; it is anticipated it will create 40 new jobs over the next five years.
"The South Carolina community has been an integral partner in our manufacturing operations for the last 20 years, and our decision to further invest in the Union facility reflects upon the diverse pool of talent, partners and resources that South Carolina has to offer," Haemonetics Corp. CEO Ron Gelbman said.
Haemonetics was launched in 1971 and is based in Braintree, Massachusetts. The company now operates from locations on four continents and employs nearly 4,000 workers all over the globe.
The Union County site, located at 155 Medical Sciences Drive in Union, has been in operation for two decades. The expansion will include an addition to the 3,000 square-foot facility and major improvements to the factory's equipment and infrastructure.
The improvements will be partially funded with a $400,000 Coordinating Council for Economic Development Rural Infrastructure Fund grant to Union County.
The Union County plant produces products for plasmapheresis, the process in which raw material for plasma therapies is collected. These products are used to treat immune deficiencies, hemophilia and other blood disorders.
“Haemonetics continues to be a great corporate partner for Union County and we are very excited about their additional investment in our community," said Union County Supervisor and Chairman of County Council Frank Hart.
Hiring for the 40 new jobs is already taking place. To apply or for more information about the company, visit www.haemonetics.com.